Observational Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 104693
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104693
Figure 1
Figure 1 Diagnostic performance of glucagon0min in identifying metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients. ROC: Receiver operating characteristic; AUC: Area under curve.